Patient X-ray exposure and ALARA in the neonatal intensive care unit: Global patterns

Amber J Gislason-Lee1

  • 1School of Allied Health Professions & Midwifery, Faculty of Health Studies, University of Bradford, UK.

Pediatrics and Neonatology
|December 22, 2020
PubMed

Insights

Neonatal intensive care units (NICUs) worldwide show varied radiation safety practices. This review highlights inconsistent X-ray use and dose management, posing risks to vulnerable premature infants and necessitating standardized protocols.

Area of Science:

  • Medical Physics
  • Neonatology
  • Public Health

Background:

  • Radiation exposure poses significant risks to neonates, particularly premature infants.
  • The cumulative effect of X-rays increases the risk of radiation-induced harm later in life.
  • Current practices in neonatal intensive care units (NICUs) regarding radiation exposure vary globally.

Purpose of the Study:

  • To review global norms for radiation practice in NICUs.
  • To assess radiation dose measurements and X-ray frequency in NICU patients.
  • To identify disparities in applying radiation safety principles like ALARA (As Low As Reasonably Achievable).

Main Methods:

  • Literature review of empirical studies published after 2000.
  • Included studies measured radiation dose in NICU settings.
  • Compared patient radiation doses, X-ray frequency, and recommendations across 25 global studies.

Main Results:

  • X-ray frequency per NICU stay ranged from 0 to 159.
  • Younger, lower birth weight infants received the most X-rays.
  • Recommendations for dose management showed no consistent pattern, indicating diverse ALARA interpretations.

Conclusions:

  • Significant global disparity exists in managing neonatal radiation exposure.
  • Inconsistent protocols pose a public health risk to neonates.
  • Standardized imaging protocols, dose limits, and monitoring are crucial for harm reduction in NICUs.

Related Concept Videos

X-ray Imaging01:24

X-ray Imaging

German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with...
9.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
134
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
806
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110